Skip to main content
. 2015 Dec 7;34(6):566–571. doi: 10.1200/JCO.2015.63.6266

Fig 2.

Fig 2.

Kaplan-Meier curves according to androgen deprivation therapy (ADT) use for the cumulative probability of remaining Alzheimer’s disease–free (y-axis) from the initiation of ADT, for ADT users, or from the time of prostate cancer diagnosis plus the median time to ADT use, for non-ADT users (x-axis), in the full (A) and propensity score–matched (B) cohorts. AD, Alzheimer’s disease; ADT, androgen deprivation therapy.